Antonio Luciano

2.2k total citations
54 papers, 1.7k citations indexed

About

Antonio Luciano is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Antonio Luciano has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Immunology and 21 papers in Molecular Biology. Recurrent topics in Antonio Luciano's work include Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Chemokine receptors and signaling (7 papers). Antonio Luciano is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Chemokine receptors and signaling (7 papers). Antonio Luciano collaborates with scholars based in Italy, United Kingdom and United States. Antonio Luciano's co-authors include Claudio Arra, Antônio Barbieri, Giuseppe Palma, Domenica Rea, Sabrina Bimonte, Aldo Pinto, Rosalinda Sorrentino, Piera Maiolino, Silvana Morello and Francesco Izzo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Antonio Luciano

52 papers receiving 1.7k citations

Peers

Countries citing papers authored by Antonio Luciano

Since Specialization

Citations

This map shows the geographic impact of Antonio Luciano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Luciano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Luciano more than expected).

Fields of papers citing papers by Antonio Luciano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Luciano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Luciano. The network helps show where Antonio Luciano may publish in the future.

Co-authorship network of co-authors of Antonio Luciano

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Luciano. A scholar is included among the top collaborators of Antonio Luciano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Luciano. Antonio Luciano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 2023 ·Cancers ·(unknown), Renato Franco, (unknown), (unknown), Andrea Ronchi, Federica Zito Marino, Carminia Maria Della Corte, Floriana Morgillo, Alfonso Fiorelli, Antonio Luciano, Giuseppe Palma, Claudio Arra, Sabrina Battista, Laura Cerchia, Monica Fedele	8
2	Clinical outcomes of a digitally supported approach for self-management of type 2 diabetes mellitus 2023 ·Frontiers in Public Health ·Vincenzo De Luca, Lutgarda Bozzetto, (unknown), (unknown), (unknown), Antonio Luciano, (unknown), Ada Maffettone, Michele Riccio, Geremia Romano, Ernesto Rossi, Carlos Chiatti, Alexander Berler, Guido Iaccarino, Maddalena Illario, Giovanni Annuzzi	5
3	Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology? 2022 ·Journal of Cardiovascular Development and Disease ·Vincenzo Quagliariello, Manuela Giovanna Basilicata, Giacomo Pepe, (unknown), Annabella Di Mauro, Giosuè Scognamiglio, Giuseppe Palma, Vincenzo Vestuto, (unknown), Antonio Luciano, (unknown), Francesca Bruzzese, (unknown), (unknown), Carmine Ostacolo, Pietro Campiglia, Massimiliano Berretta, Nicola Maurea	15
4	Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 2022 ·Frontiers in Cardiovascular Medicine ·Vincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, (unknown), Andrea Paccone, Antônio Barbieri, Giuseppe Palma, Antonio Luciano, (unknown), Irma Bisceglia, Maria Laura Canale, Giuseppina Gallucci, Alessandro Inno, Claudia De Lorenzo, Nicola Maurea	40
5	MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response 2021 ·Frontiers in Immunology ·Maria Tagliamonte, Angela Mauriello, Beatrice Cavalluzzo, Concetta Ragone, (unknown), Antonio Luciano, Antônio Barbieri, Giuseppe Palma, Giosuè Scognamiglio, Annabella Di Mauro, Maurizio Di Bonito, Maria Lina Tornesello, Luigi Buonaguro, Luigi Vitagliano, Andrea Caporale, Menotti Ruvo	5
6	Naloxone Counteracts the Promoting Tumor Growth Effects Induced by Morphine in an Animal Model of Triple-negative Breast Cancer 2019 ·In Vivo ·Sabrina Bimonte, Antônio Barbieri, Marco Cascella, Domenica Rea, Giuseppe Palma, Antonio Luciano, Cira Antonietta Forte, Arturo Cuomo, Claudio Arra	15
7	CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells 2019 ·Cell Death and Disease ·Caterina Ieranò, Crescenzo D’Alterio, (unknown), Maria Napolitano, Giuseppina Rea, Luigi Portella, (unknown), Anna Maria Trotta, Antônio Barbieri, Virginia Campani, Antonio Luciano, Claudio Arra, Anna Maria Anniciello, Gerardo Botti, Laura Mayol, Giuseppe De Rosa, Roberto Pacelli, Stefania Scala	17
8	The effects of the use of platelet-rich plasma gel on local recurrence in an animal model of human fibrosarcoma 2019 ·Infectious Agents and Cancer ·Antônio Barbieri, Sabrina Bimonte, Giovanna Loquercio, Domenica Rea, Marco Cascella, (unknown), Antonio Luciano, Giuseppe Palma, (unknown), Rosa Azzaro, (unknown), Claudio Arra	9
9	Enhanced stability of organic field-effect transistor biosensors bearing electrosynthesized ZnO nanoparticles 2018 ·Sensors and Actuators B Chemical ·Rosaria Anna Picca, Kyriaki Manoli, Antonio Luciano, Maria Chiara Sportelli, Gerardo Palazzo, Luisa Torsi, Nicola Cioffi	23
10	HMGA2 cooperates with either p27^kip1 deficiency or Cdk4^R24C mutation in pituitary tumorigenesis 2017 ·Cell Cycle ·Monica Fedele, Orlando Paciello, Davide De Biase, Mario Monaco, Gennaro Chiappetta, (unknown), Antônio Barbieri, Domenica Rea, Antonio Luciano, Serenella Papparella, Claudio Arra, Alfredo Fusco	10
11	A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors 2017 ·Scientific Reports ·Sara Santagata, Luigi Portella, Maria Napolitano, Adelaide Greco, Crescenzo D’Alterio, Maria Vittoria Barone, Antonio Luciano, Matteo Gramanzini, Luigi Auletta, Claudio Arra, Antonella Zannetti, Stefania Scala	18
12	The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo 2015 ·International Journal of Oncology ·Antônio Barbieri, Sabrina Bimonte, Giuseppe Palma, Antonio Luciano, Domenica Rea, Aldo Giudice, Giosuè Scognamiglio, Elvira La Mantia, Renato Franco, Sisto Perdonà, Ottavio De Cobelli, Matteo Ferro, Silvia Zappavigna, Paola Stiuso, Michele Caraglia, Claudio Arra	77
13	Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer 2014 ·International Journal of Pharmaceutics ·Giuseppe Palma, Claudia Conte, Antônio Barbieri, Sabrina Bimonte, Antonio Luciano, Domenica Rea, Francesca Ungaro, Pasquale Tirino, Fabiana Quaglia, Claudio Arra	34
14	O unheimliche em “Páramo” de Guimarães Rosa 2013 ·SHILAP Revista de lepidopterología ·Antonio Luciano	1
15	Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways 2013 ·Cell Death and Disease ·Francesca Bruzzese, Biagio Pucci, Maria Rita Milone, Chiara Ciardiello, Renato Franco, (unknown), Monica Rocco, Elena Di Gennaro, Alessandra Leone, Antonio Luciano, Claudio Arra, Daniele Santini, Michele Caraglia, Alfredo Budillon	47
16	Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases 2013 ·PLoS ONE ·Luigi Portella, Rosa Maria Vitale, Stefania De Luca, Crescenzo D’Alterio, Caterina Ieranò, Maria Napolitano, Anna Riccio, (unknown), Luca Monfregola, Antônio Barbieri, Antonio Luciano, Andrea Ciarmiello, Claudio Arra, Giuseppe Castello, Pietro Amodeo, Stefania Scala	76
17	B Cells Contribute to the Antitumor Activity of CpG-Oligodeoxynucleotide in a Mouse Model of Metastatic Lung Carcinoma 2011 ·American Journal of Respiratory and Critical Care Medicine ·Rosalinda Sorrentino, Silvana Morello, Giovanni Forte, Antonella Montinaro, (unknown), Antonio Luciano, Giuseppe Palma, Claudio Arra, Piera Maiolino, Ian M. Adcock, Aldo Pinto	61
18	NK1.1+ Cells and CD8+ T Cells Mediate the Antitumor Activity of Cl-IB-MECA in a Mouse Melanoma Model 2011 ·Neoplasia ·Silvana Morello, Rosalinda Sorrentino, Antonella Montinaro, Antonio Luciano, Piera Maiolino, Anta Ngkelo, Claudio Arra, Ian M. Adcock, Aldo Pinto	23
19	Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase 2010 ·British Journal of Cancer ·Elena Di Gennaro, Geny Piro, (unknown), Renato Franco, (unknown), Tania Moccia, Antonio Luciano, Immacolata Ruggiero, Francesca Bruzzese, Antonio Avallone, Claudio Arra, Alfredo Budillon	36
20	A astronomia de Os Lusíadas 1972 ·Imprensa da Universidade de Coimbra eBooks ·(unknown), Antonio Luciano	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact